Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Morrato, Elaine H
2012.
An update on lipid profile screening in second-generation antipsychotic users in the USA.
Clinical Lipidology,
Vol. 7,
Issue. 5,
p.
509.
Papanastasiou, Evangelos
2012.
Interventions for the metabolic syndrome in schizophrenia: a review.
Therapeutic Advances in Endocrinology and Metabolism,
Vol. 3,
Issue. 5,
p.
141.
De Hert, Marc
Detraux, Johan
van Winkel, Ruud
Yu, Weiping
and
Correll, Christoph U.
2012.
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
Nature Reviews Endocrinology,
Vol. 8,
Issue. 2,
p.
114.
Mitchell, Alex J
2012.
Understanding disproportionately high cardiometabolic risk in Australians treated for psychosis.
Australian & New Zealand Journal of Psychiatry,
Vol. 46,
Issue. 10,
p.
919.
van Gool, Ronald
and
van Meijel, Berno
2012.
Mind the body!.
Nederlands Tijdschrift voor Evidence Based Practice,
Vol. 10,
Issue. 2,
p.
4.
Binford, Sandra Haas
Johnson, Monique D.
Kennedy, Robert S.
and
Leffler, Joy Bartnett
2012.
Clinician Education Improves Lipid Monitoring in Patients Taking Second-Generation Antipsychotic Agents, Nationally and Locally.
Health Outcomes Research in Medicine,
Vol. 3,
Issue. 3,
p.
e121.
Galletly, Cherrie A
Foley, Debra L
Waterreus, Anna
Watts, Gerald F
Castle, David J
McGrath, John J
Mackinnon, Andrew
and
Morgan, Vera A
2012.
Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis.
Australian & New Zealand Journal of Psychiatry,
Vol. 46,
Issue. 8,
p.
753.
Mitchell, Alex J.
Delaffon, Vijay
and
Lord, Oliver
2012.
Let's get physical: improving the medical care of people with severe mental illness.
Advances in Psychiatric Treatment,
Vol. 18,
Issue. 3,
p.
216.
Vancampfort, D.
Probst, M.
Scheewe, T.
Knapen, J.
De Herdt, A.
and
De Hert, M.
2012.
The functional exercise capacity is correlated with global functioning in patients with schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 125,
Issue. 5,
p.
382.
Mitchell, Alex J.
2012.
Psychiatric aspects of chronic physical disease.
Medicine,
Vol. 40,
Issue. 12,
p.
662.
Lahti, M.
Tiihonen, J.
Wildgust, H.
Beary, M.
Hodgson, R.
Kajantie, E.
Osmond, C.
Räikkönen, K.
and
Eriksson, J.
2012.
Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia.
Psychological Medicine,
Vol. 42,
Issue. 11,
p.
2275.
Mitchell, A. J.
Vancampfort, D.
De Herdt, A.
Yu, W.
and
De Hert, M.
2013.
Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients.
Schizophrenia Bulletin,
Vol. 39,
Issue. 2,
p.
295.
Miller, Brian J.
Mellor, Andrew
and
Buckley, Peter
2013.
Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses.
Brain, Behavior, and Immunity,
Vol. 31,
Issue. ,
p.
82.
Foley, Debra L.
Mackinnon, Andrew
Watts, Gerald F.
Shaw, Jonathan E.
Magliano, Dianna J.
Castle, David J.
McGrath, John J.
Waterreus, Anna
Morgan, Vera A.
Galletly, Cherrie A.
and
Vinciguerra, Manlio
2013.
Cardiometabolic Risk Indicators That Distinguish Adults with Psychosis from the General Population, by Age and Gender.
PLoS ONE,
Vol. 8,
Issue. 12,
p.
e82606.
Owen, Richard R
Drummond, Karen L
Viverito, Kristen M
Marchant, Kathy
Pope, Sandra K
Smith, Jeffrey L
and
Landes, Reid D
2013.
Monitoring and managing metabolic effects of antipsychotics: a cluster randomized trial of an intervention combining evidence-based quality improvement and external facilitation.
Implementation Science,
Vol. 8,
Issue. 1,
Lang, Donna J.
Barr, Alasdair M.
and
Procyshyn, Ric M.
2013.
Management of Medication-Related Cardiometabolic Risk in Patients with Severe Mental Illness.
Current Cardiovascular Risk Reports,
Vol. 7,
Issue. 4,
p.
283.
Skelton, Mike
Thacker, Simon
Forbes-Haley, Andrew
Kumar, Mahendra
and
Holliday, Eleanor
2013.
Psychiatrists' access to electronic laboratory results.
The Psychiatrist,
Vol. 37,
Issue. 5,
p.
160.
Eapen, Valsamma
Shiers, David
and
Curtis, Jackie
2013.
Bridging the gap from evidence to policy and practice: Reducing the progression to metabolic syndrome for children and adolescents on antipsychotic medication.
Australian & New Zealand Journal of Psychiatry,
Vol. 47,
Issue. 5,
p.
435.
Murphy, Andrea Lynn
Gardner, David Martin
Kisely, Steve
Cooke, Charmaine
Kutcher, Stanley Paul
and
Hughes, Jean
2013.
Youth, Caregiver, and Prescriber Experiences of Antipsychotic-Related Weight Gain.
ISRN Obesity,
Vol. 2013,
Issue. ,
p.
1.
Butler, Phalyn
Simonson, Caitlin
Goldie, Christa
Kennedy, Amy
and
Goldstone, Lisa W.
2013.
Baseline metabolic monitoring of atypical antipsychotics in an inpatient setting.
Mental Health Clinician,
Vol. 3,
Issue. 3,
p.
122.